Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedA new 'Revision: v3.5.4' entry was added to the record history, replacing the previous version tag. This update reflects a minor change to the page's versioning metadata rather than substantive content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page’s displayed application/release revision updated from v3.5.2 to v3.5.3, indicating a minor site software/version update rather than a change to the study record itself.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.1%

- Check78 days agoChange DetectedThe history log now shows an addition of Revision v3.5.0 and a deletion of Revision v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded Study Status and Recruitment Status entries, including Terminated and Sponsor decision dated 2026-02-23 and 2026-02-20. The previous 'Active, not recruiting' status from 2024-08-01 was removed.SummaryDifference0.8%

- Check114 days agoChange DetectedAdded revision v3.4.2 to the record history and removed v3.4.1. These are minor maintenance changes that do not affect study data or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.